Intraperitoneal drug therapy: Physical and biological principles

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 131-152

  Flessner, Michael F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875011282     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_8     Document Type: Chapter

References (111)

1. Vazquez VdL, Stuart OA, Mohamed F, Sugarbaker P (2003) Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Rep 52:108-112
2. Yazbeck C, Dhainaut C, Batallan A, Benifila J-L, Thoury A, Madelenat P (2005) Diagnostic hysteroscopy and risk of peritoneal dissemination of tumor cells. Gynecol Obstet Fertil 33:247-252
3. Ludeman L, Shepherd N (2005) Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology 47:123-131
4. Colcher D, Esteban J, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G et al (1987) Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res 47:4218-4224
5. Oosterling S, van der Bij GJ, van Egmond M, van der Sijp J (2005) Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 31:29-37
6. Lopez-Berlanga J, De Miguel A, Elvira A (2004) Anesthesia and postoperative care of 11 patients undergoing peritonectomy and hypothermic intraperitoneal chemotherapy. Revista Espanola de Anesthesiologia y Reanimacion 51:423-428
7. Chagnac A, Herskovitz P, Weinstein T, Elyashiv S, Hirsh J, Hamel I, Gafter U (1999) The peritoneal membrane in peritoneal dialysis patients: estimation of its functional surface area by applying stereologic methods to computerized tomography scans. J Am Soc Nephrol 10:342-346
8. Chagnac A, Herskovitz P, Ori Y, Weinstein T, Hirsh J, Katz M, Gafter U (2002) Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients. J Am Soc Nephrol 13:2554-2559
9. Flessner MF, Lofthouse J, Zakaria EL (2001) Improving contact area between the peritoneum and intraperitoneal therapeutic solutions. J Am Soc Nephrol 12:807-813
10. Flessner MF, Lofthouse J, Williams A (2001) Increasing peritoneal contact area during dialysis improves mass transfer. J Am Soc Nephrol 12:2139-2145
11. Markman M (1998) Intraperitoneal therapy of ovarian carcinoma. Semin Oncol 25:356-360
12. Fujiwara K, Markman M, Morgan M, Coleman RL (2005) Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer. Gynecol Oncol 97:10-5
13. Gershenson DM, Tortolero-Luna G, Malpica A, Baker VV, Whitaker L, Johnson E, Mitchell MF (1996) Ovarian intraepithelial neoplasia and ovarian cancer. Obstetrics and Gyencol Clinics of North America 23:475-543
14. Dedrick RL, Myers CE, Bungay PM, DeVita VT (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1
15. Flessner MF, Dedrick R (2000) Intraperitoneal chemotherapy. In: Gokal R, Khanna R, Krediet RT, Nolph K, eds. Textbook of Peritoneal Dialysis. Dordrecht, Netherlands: Kluwer Academic Publishers p809-827
16. Goel R, Cleary S, Horton C, Howell S (1989) Effect sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Nat Cancer Inst 81:1552-1560
17. Piccart M, Abrams J, Dodian P, et al (1988) Intraperitoneal chemotherapy with cisplatin and melphalan. J Nat Cancer Inst 80:1118-1124
18. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW, Myers CE (1981) Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 41:1916
19. Sugarbaker P, Graves T, DeBruijn E, et al (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Caner Res 50:5790-5794
20. Selam J-L, Bergman R, Raccah D, Jean-Didier N, Lozano J, Charles M (1990) Determination of portal insulin absorption from peritoneum via novel non-isotopic method. Diabetes 39:1361-1365
21. Dedrick RL, Flessner MF (1989) Pharmacokinetic considerations on monoclonal antibodies. Immunity to Cancer II:429-438
22. Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E et al (2002) Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 20:694-698
23. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. New Engl J Med 335:1950-1955
24. Krediet RT (2000) Physiology of peritoneal solute transport and ultrafiltration. In: Gokal R, Khanna R, Krediet RT, Nolph K, eds. Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers, 135-172
25. Babb AL, Johansen PJ, Strand MJ, Tenckhoff H, Scribner BH (1973) Bidirectional permeability of the human peritoneum to middle molecules. Proc Eur Dial Transplant Assoc 10:247
26. Jacquet P, Averbach A, Stephens A, Stuart O, Chang D, Sugarbaker P (1998) Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 55:130-138
27. Elias D, Bonnay M, Puizillou J, Antoun S, Demirdjian S, ElOtmany A et al (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13:267-272
28. Steller M, Egorin MJ, Trimble E, Bartlett D, Suhowski E, Alexander H, Dedrick R (1999) A pilot phase I trial of continuous hyperthermic periotoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer. Cancer Chemother Pharmacol 43:106-114
29. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC (1994) Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 4:1820-1826
30. Torres IJ, Litterst CI, Guarino AM (1978) Transport of model compounds across the peritoneal membrane in the rat. Pharmacology 17:161-166
31. Lewis C, Lawson N, Rankin E, et al (1990) Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer. Cancer Chemother Pharmacol 26:283-287
32. Wikes A, Howell S (1985) Pharmacokinetics of hexamethylmelamine administered via the ip route in an oil emulsion vehicle. Cancer Treat Rep 69:657-662
33. Flessner MF (1996) Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 7:225-233
34. Flessner MF, Dedrick RL, Schultz JS (1984) A distributed model of peritoneal-plasma transport: theoretical consideratons. Am J Physiol 246:R597-R607
35. Dedrick RL, Flessner MF, Collins JM, Schultz JS (1982) Is the peritoneum a membrane? Am Soc Artificial Intern Organs J 5:1-5
36. Flessner M.F., Lofthouse J., Zakaria ER (1997) In vivo diffusion of immunoglobulin G in muscle: effects of binding, solute exclusion, and lymphatic removal. Am J Physiol 273:H2783-H2793
37. Flessner M.F (2001) Transport of protein in the abdominal wall during intraperitoneal therapy I. Theoretical approach. Am J Physiol Gastrointest Liver Physiol 281:G424-G437
38. Baron MA (1941) Structure of the intestinal peritoneum in man. Am J Anat 69:439-497
39. Flessner MF (1992) Net ultrafiltration in peritoneal dialysis: Role of direct fluid absorption into peritoneal tissue. Blood Purif 10:136-147
40. Rippe B, Stelin G, Ahlmen J (1986) Frontiers in Peritoneal Dialysis. New York: Field, Rich, p24-30
41. Heimburger O, Waniewski J, Werynski A, Park MS, Lindholm B (1994) Lymphatic absorption in CAPD patients with loss of ultrafiltration capacity. In: Heimburger O, ed. PhD Thesis. Stockholm: Konogl Carolinska Medico Chirurgiska Institute, 1-21
42. Daugirdas JT, Ing TS, Gandhi VC, Hano JE, Chen WT, Yuan L (1980) Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med 85:351-361
43. Flessner MF (1991) Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 2:122-135
44. Granger DN, Parker RE, Quillen EW, Brace RA, Taylor AE (1979) Lymphology. Stuttgart, FRG: Thieme, p61-64
45. Yoffey JM, Courtice FC (1970) Lymphatics, Lymph, and the Lymphomyeloid Complex. London, UK: Academic, p320
46. Courtice FC, Steinbeck AW (1951) Absorption of protein from the peritoneal cavity. J Physiol London 114:336-355
47. Flessner MF, Schwab A (1996) Pressure threshold for fluid loss from the peritoneal cavity. Am J Physiol 270:F377-F390
48. Flessner M.F., Henegar J, Bigler S, Genous L (2003) Is the peritoneum a significant transport barrier in peritoneal dialysis? Perit Dial Int 23:542-549
49. Hekking LHP, Harvey VS, Havenith CEG, van den Born J, Beelen RHJ, Jackman RW, Nagy JA (2003) Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial Int 23:323-330
50. Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J (2001) Gene transfer of transforming growth factor-Beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 12:2029-2039
51. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gaudie J (2002) Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728
52. Jackman RW, Hoff CM, Shockley TR, Nagy JA (1999) Adenovirus-mediated transfer of rat catalase cDNA into rat primary mesothelial cells confers increased resistance to oxidant-induced injury in vitro. J Am Soc Nephrol 10:446A-447A
53. Hoff CM, Piscopo D, Inman K, Shockley TR (2000) Adenovirus-mediated gene transfer to the peritoneal cavity. Perit Dial Int 20:128-136
54. Alvarez RD, Curiel D (1997) A phase I study of recombinant adenovirus ventor-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous gangciclovir for previously treated ovarian and extraovarian cancer patients. Hum Gene Ther 8:597-613
55. Mujoo K, Maneval D, Anderson S, Gutterman J (1996) Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene 12:1617-1623
56. Tong X-W, Block A, Chen S-H, Contact C, Agoulnik I, Blankenburg K et al (1996) In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and gangciclovir administration. Gynec Oncol 61:175-179
57. deForni M, Boneu A, Otal P, Martel P, Shubinski R, Bugat R, Lucot H (1993) Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic peritoneography. Bulletin du Cancer 80:345-350
58. Reed RK, Rubin K, Wiig H, Rodt SA (1992) Blockade of β1-integrins in skin causes edema through lowering of interstitial fluid pressure. Circ Res 71:978-983
59. Rubin K, Sundberq C, Ahlen K, Reed RK (1995) Integrins: transmembrane links between the extracellular matrix and the cell interior. In: Reed RK, Mattale NG, Bert JL, Winlove CP, Laine GA, eds. Interstitium, Connective Tissue, and Lymphatics. London: Portland Press Ltd, 29-40
60. Rubin K, Gullberg D, Tomasini-Johansson B, Reed RK, Ryden C, Borg TK (1996) Molecular recognition of the extracellular matrix by cell surface receptors. In: Comper WD, ed. Extracellular Matrix. Amsterdam: Harwood Academic Publishers, p262-309
61. Laurent TC (1995) Structure of the extracellular matrix and the biology of hyaluronan. In: Reed RK, McHale NG, Bert JL, Winlove CP, Laine GA, eds. Interstitium, Connective Tissue, and Lymphatics. London: Portland Press, p1-12.
62. Fraser JRE, Laurent TC (1996) Hyaluronan. In: Comper WD, ed. Extracellular Matrix. Amsterdam: Harwood Academic Publishers, 141-199
63. Wiig H, DeCarlo M, Sibley L, Renkin EM (1992) Interstitial exclusion of albumin in rat tissues measured by a continous infusion method. Am J Physiol 263:H1222-H1233
64. Wiig H, Kaysen GA, Al-Bander HA, DeCarlo M, Sibley L, Renkin EM (1994) Interstitial exclusion of IgG in rat tissues estimated by continuous infusion. Am J Physiol 266:H212-H219
65. Zakaria ER, Lofthouse J, Flessner MF (1999) In vivo effects of hydrostatic pressure on interstitium of abdominal wall muscle. Am J Physiol 276:H517-H529
66. Zakaria ER, Lofthouse J, and Flessner MF (2000) Effect of intraperitoneal pressures on tissue water of the abdominal muscle. Am J Physiol Renal Physiol 278:F875-F885
67. Zakaria ER, Lofthouse J, Flessner MF (1997) In vivo hydraulic conductivity of muscle: effects of hydrostatic pressure. Am J Physiol 273:H2774-H2782
68. Twardowski ZJ, Prowant BF, Nolph KD (1983) High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 23:64-70
69. Gotloib L, Mines M, Garmizo L, Varka I (1981) Hemodynamic effects of increasing intra-abdominal pressure in peritoneal dialysis. Peritoneal Dial Bull 1:41-43
70. Flessner MF, Dedrick RL, Reynolds JC (1992) Bidirectional peritoneal transport of immunoglobulin in rats: tissue concentration profiles. Am J Physiol 263:F15-F23
71. Flessner M.F (1999) Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit Dial Int 19 Suppl 2:S77-S82
72. Flessner MF (2005) The transport barrier in intraperitoneal therapy. Am J Physiol 288:F433-F442
73. Wiig H, Reed RK, Aukland K (1981) Micropuncture measurement of interstitial fluid pressure in rat subcutis and skeletal muscle: comparison to the wickin-needle technique. Microvasc Res 21:308-319
74. Wiig H, Reed RK (1985) Interstitial compliance and transcapillary Starling pressures in cat skin and skeletal muscle. Am J Physiol 248:H666-H673
75. Flessner MF, Choi J, Credit K, Deverkadra R, Henderson K (2005) Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clin Cancer Res 11:3117-3125
76. Flessner MF, Choi J, He Z, Credit K (2004) Physiological characterization of human ovarian cancer cells in a rat model of intraperitoneal antineoplastic therapy. J Appl Physiol 97:1518-1526
77. Boucher Y, Baxter LT, Jain RK (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478-4484
78. Boucher Y, Kirkwood JM, Opacic D, Desantis M, Jain RK (1991) Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res 51:6691-6694
79. Roh HD, Boucher Y, Kalnicki S, Buchsbaum R, Bloomer WD, Jain RK (1991) Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation exposure. Cancer Res 51:6695-6698
80. Flessner MF (1981) Transport of Water-Soluble Solutes Between the Peritoneal Cavity and Plasma in the Rat. Ann Arbor, MI: Univ. of Michigan
81. Gullino PM, Grantham FH, Smith SH (1965) The interstitial water space of tumors. Cancer Res 25:727-731
82. Boucher Y, Jain RK (1992) Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52:5110-5114
83. Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47:3039-3051
84. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK (2000) Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Research 60:2497-2503
85. Choi J, Credit K, Henderson K, Deverkadra R, He Z, Wiig H et al (2006) Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration. Clin Cancer Res 12:1906-1912
86. Flessner MF, Fenstermacher JD, Dedrick RL, Blasberg RG (1985) A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol 248:F425-F435
87. Vink H, Duling BR (1996) Identification of distinct luminal domains for macromolecules, erythrocytes, and leucocytes within mammalian capillaries. Circ Res 79:581-589
88. Vink H, Duling BR (2000) Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol 278:H285-H289
89. Fu B, Curry FE, Adamson RH, Weinbaum S (1997) A model for interpreting the tracer labeling of interendothelial clefts. Ann Biomed Engin 25:375-397
90. Fu BM, Curry FE, Weinbaum S (1995) A diffusion wake model for tracer ultrastructure-permeability studies in microvessels. Am J Physiol 269:H2124-H2140
91. Platts SH, Duling BR (2004) Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx. Circ Res 94:77-82
92. Matsuki T, Duling B (2000) TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Microcirculation 7:411-418
93. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK (1992) Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 52:6553-6650
94. Nugent LJ, Jain RK (1984) Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed. Am J Physiol 246:H129-H137
95. Yuan F, Leunig M, Berk DA, Jain RK (1993) Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 45:269-289
96. Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31:288-305
97. Henry CBS, Duling BR (2000) TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol 279:H2815-H2823
98. Bettendorf U (1978) Lymph flow mechanism of the subperitoneal diaphragmatic lymphatics. Lymphology 11:111-116
99. Bettendorf U (1979) Electronmicroscopic studies on the peritoneal resorption of intraperitioneally injected latex particles via the diaphragmatic lymphatics. Lymphology 12:66-70
100. Courtice FC, Steinbeck AW (1951) The effects of lymphatic obstruction and of posture on absorption of protein from the peritoneal cavity. Aust J Exp Biol Med Sci 29:451-458
101. Dykes PW, Jones JH (1964) Albumin exchange between plasma and ascites fluid. Clin Sci 34:185-197
102. Rusznysk I, et al (1967) Lymphatics and Lymph Circulation. London: Pergamon Press
103. Baxter LT, Jain RK (1989) Transport of fluid and macromolecules in tumor. I. Role of interstitial pressure and convection. Microvasc Res 37:77-104
104. Hosie KB, Gilbert J, Kerr DJ, Brown C, Peers E (2001) Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Delivery 8:9-12
105. Hosie KB, Kerr DJ, Gilbert JA, Downes M, Lakin G, Pemberton G et al (2003) A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution. Eur J Surg Oncol 29:254-260
106. Penzotti SC, Mattocks AM (1968) Acceleration of peritoneal dialysis by surface active agents. J Pharm Sci 57:1192-1195
107. van Ruth S, Mathot R, Sparidans R, Beijnen J, Verwaal V, Zoetmulder F (2004) Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokin 43:131-143
108. Witkamp A, deBree E, VanGoethem R, Zoetmulder F (2001) Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27:365-374.
109. Los G, Mutsaers PHA, van der Vijgh WJF, Baldera GS, de Graag PW, McVie JG (1989) Direct diffusion of cis-diaminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: A comparison with systemic chemotherapy. Cancer Res 49:3380-3384
110. Ozols RF, Locker GY, Doroshow JH (1979) Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39:3209-3214
111. Flessner MF, Deverkadra R, Smitherman J, Li X, Credit K (2006) In vivo determination of diffusive transport parameters in a superfused tissue. Am J Physiol Renal Physiol, In press